Chronic GVHD-specific survival.

Probability of survival in years after the diagnosis of cGVHD in 151 allogeneic BMT patients. (A) Median follow-up of the 68 patients surviving was 7.8 years (range, 0.2-20.6) after diagnosis of cGVHD. (B) Probability of survival in years after diagnosis of cGVHD of patients grouped by their calculated PFS1. Patients were grouped as low, intermediate, high, and very high risk if their PFS1 was 0 (n = 54), less than 2 (n = 30), 2 to 3.5 (n = 28), and more than 3.5 (n = 39) at the diagnosis of cGVHD (P values = .05, < .001, and < .001), respectively. (C) Probability of survival in years after diagnosis of cGVHD of patients grouped by the total number of risk factors. Patients were grouped as low, intermediate, and high risk if they had none (n = 54), 1 or 2 (n = 58), and 3 risk factors (n = 39) present at the diagnosis of cGVHD, respectively.